HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Annexin A2 (Annexin II)

A member of the annexin family that is a substrate for a tyrosine kinase, ONCOGENE PROTEIN PP60(V-SRC). Annexin A2 occurs as a 36-KDa monomer and in a 90-KDa complex containing two subunits of annexin A2 and two subunits of S100 FAMILY PROTEIN P11. The monomeric form of annexin A2 was formerly referred to as calpactin I heavy chain.
Also Known As:
Annexin II; Annexin A2, P90 Complex; Annexin II, P36; Annexin II, P90 Complex; Capactin I Heavy Chain; P36 Annexin II; Calpactin I; Lipocortin II
Networked: 660 relevant articles (8 outcomes, 100 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Vishwanatha, Jamboor K: 18 articles (10/2021 - 09/2003)
2. Hajjar, Katherine A: 14 articles (06/2021 - 02/2002)
3. Wang, Xiaoying: 11 articles (08/2021 - 06/2010)
4. Yu, Zhanyang: 9 articles (01/2021 - 06/2010)
5. Zhang, Wei: 8 articles (10/2021 - 02/2010)
6. Shetty, Praveenkumar: 8 articles (10/2021 - 03/2010)
7. Jiang, Yinghua: 7 articles (08/2021 - 01/2015)
8. Liu, Ning: 7 articles (08/2021 - 10/2010)
9. Oehler, Martin K: 7 articles (01/2021 - 08/2011)
10. Ricciardelli, Carmela: 7 articles (01/2021 - 08/2011)

Related Diseases

1. Neoplasms (Cancer)
2. Breast Neoplasms (Breast Cancer)
3. Pancreatic Neoplasms (Pancreatic Cancer)
4. Ischemia
5. Diabetic Retinopathy (Retinopathy, Diabetic)

Related Drugs and Biologics

1. Proteins (Proteins, Gene)
2. Tissue Plasminogen Activator (Alteplase)
3. Plasminogen
4. Peptides (Polypeptides)
5. Small Interfering RNA (siRNA)
6. Gemcitabine
7. Tyrosine (L-Tyrosine)
8. Coloring Agents (Dyes)
9. Drug Combinations
10. Biomarkers (Surrogate Marker)

Related Therapies and Procedures

1. Therapeutics
2. Neoadjuvant Therapy
3. Drug Therapy (Chemotherapy)
4. Adjuvant Chemotherapy
5. Immunotherapy